Edwards Lifesciences Corp (EW) Stock Price Today—Real Time Charts and Quotes

Q: What are the 52-week high and low prices for Edwards Lifesciences Corp (EW)?

EW has a 52-week high of $0 and a 52-week low of $0, with the current price at $0.

Q: What is the price-to-earnings (P/E) ratio of Edwards Lifesciences Corp (EW)? What does it indicate?

The current P/E ratio (TTM) of EW is 46.440801117838845, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Medical - Devices industry for a better context.

Q: What is the market cap of Edwards Lifesciences Corp (EW)?

Edwards Lifesciences Corp (EW) currently has a market cap of approximately $48.11B.

Q: What is the most recent quarterly earnings per share (EPS) for Edwards Lifesciences Corp (EW)?

Edwards Lifesciences Corp (EW)'s diluted earnings per share (Diluted EPS) is 1.8867403314917126. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Edwards Lifesciences Corp (EW) now?

As of now, EW is trading at $0, with a P/E ratio of 46.440801117838845 and a diluted EPS of 1.8867403314917126. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Edwards Lifesciences Corp's financial reports, the outlook of the Medical - Devices sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Edwards Lifesciences Corp (EW)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Medical - Devices sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Edwards Lifesciences Corp (EW) stock?

You can buy Edwards Lifesciences Corp (EW) through Gate. Sign up for a Gate account and complete identity verification, then go to the Edwards Lifesciences Corp trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

+$0(0,00 %)

Keine Daten

*Data last updated: 2026-04-28 13:10 (UTC+8)

As of 2026-04-28 13:10, Edwards Lifesciences Corp (EW) is priced at $0, with a total market cap of $48,11B, a P/E ratio of 46,44, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $0 and $0. The current price is 0,00 % above the day's low and 0,00 % below the day's high, with a trading volume of 6,06M. Over the past 52 weeks, EW has traded between $0 to $0, and the current price is 0,00 % away from the 52-week high.

EW Key Stats

Yesterday's Close$84

Market Cap$48,11B

Volumen6,06M

P/E Ratio46,44

Dividend Yield (TTM)0,00 %

Diluted EPS (TTM)1,88

Net Income (FY)$1,07B

Revenue (FY)$6,06B

Earnings Date2026-07-23

EPS Estimate0,75

Revenue Estimate$1,70B

Shares Outstanding571,81M

Beta (1Y)0.945

About EW

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

SectorHealthcare

IndustryMedical - Devices

CEOBernard J. Zovighian

HeadquartersIrvine,CA,US

Official Websitehttps://www.edwards.com

Employees (FY)16,00K

Average Revenue (1Y)$379,22K

Net Income per Employee$67,09K

Erfahren Sie mehr über Edwards Lifesciences Corp (EW)

Gate Learn Articles

SKATE: Ein neues Infrastrukturprotokoll, das die Barrieren zwischen den Chains aufbricht

Erfahren Sie, wie SKATE die Barrieren zwischen Ketten überwindet, indem es EVM, SolanaVM und TonVM verbindet, um ein benutzerfreundliches Erlebnis und eine entwicklerfreundliche Umgebung zu schaffen, die die Entwicklung von Cross-Chain-Anwendungen fördert.

2025-06-12

Überblick über repräsentative Meme-Projekte in verschiedenen öffentlichen Ketten, von Silly Dragon bis Minu

In diesem Artikel werden repräsentative Meme-Projekte zu verschiedenen Lieferketten vorgestellt.

2024-01-09

Algorand Preisupdate: Netzwerkwachstum treibt Preiserholung an

Dieser Artikel bietet eine umfassende Interpretation der neuesten Trends im Algorand-Preis, einschließlich aktueller Preise, historischer Schwankungen, Interpretation von Daten zu aktiven Adressen und Transaktionsvolumen sowie der Kombination des Anstiegs des Netzwerks am 11. Juni mit aktuellen Marktneuigkeiten, um neuen Nutzern zu helfen, den Marktkontext und Investitionsmöglichkeiten schnell zu erfassen und praktische Referenzen sowie prägnante Handlungsvorschläge für Ihre Entscheidungsfindung zu liefern.

2025-06-12

Edwards Lifesciences Corp (EW) FAQ

What's the stock price of Edwards Lifesciences Corp (EW) today?

Edwards Lifesciences Corp (EW) is currently trading at $0, with a 24h change of 0,00 %. The 52-week trading range is $0–$0.

What are the 52-week high and low prices for Edwards Lifesciences Corp (EW)?

What is the price-to-earnings (P/E) ratio of Edwards Lifesciences Corp (EW)? What does it indicate?

What is the market cap of Edwards Lifesciences Corp (EW)?

What is the most recent quarterly earnings per share (EPS) for Edwards Lifesciences Corp (EW)?

Should you buy or sell Edwards Lifesciences Corp (EW) now?

What factors can affect the stock price of Edwards Lifesciences Corp (EW)?

How to buy Edwards Lifesciences Corp (EW) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.